CreditReports.dk
HomeScreen companies

PHARMA NORD ApS Financials, key figures and credit report

CVR number: 67303016 Established 1981 Industry: 10 Manufacture of food products
Company contact details
Tinglykke 4-6, Skrydstrup 6500 Vojens tel: 74541155
Net sales 571.1 mDKK FY 2025 +4.4% vs 2024
EBIT margin 7.2 % FY 2025 -1.9 pp vs 2024
Net debt 187.6 mDKK FY 2025 +17.5% vs 2024
Quick ratio 0.6 FY 2025 +0 vs 2024

Income statement (mDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales535.76492.26505.77547.17571.12
Manufacturing for enterprise's own use-3.49-3.59-1.90-2.29-3.04
Other operating income1.602.571.771.782.35
Purchases during the financial year- 106.03-86.55- 114.78- 125.92- 111.19
External services- 139.59- 156.16- 165.35- 168.93- 197.18
Gross profit295.23255.71229.32256.39268.14
Employee benefit expenses- 205.67- 193.16- 177.81- 191.62- 210.93
Other operating expenses-0.03-0.99-0.54
Total depreciation-12.48-13.60-13.55-14.03-15.33
EBIT77.0548.9537.9649.7641.35
Other financial income0.890.310.431.932.32
Other financial expenses-3.11-3.80-8.88-10.45-8.12
Income from other inv. held as non-curr. assets0.010.010.01
Pre-tax profit74.8545.4829.5341.2435.55
Income taxes-16.08-10.15-6.83-8.68-8.33
Net earnings58.7735.3322.7132.5627.21

Assets (mDKK)

2021
2022
2023
2024
2025
Development expenditure1.081.091.462.812.99
Goodwill0.000.080.04
Intangible assets total1.081.091.542.862.99
Land and waters163.02162.46163.41164.67199.40
Buildings11.3210.9712.7513.8326.72
Machinery and equipment23.3822.8921.4019.5921.32
Advance payments and construction in progress2.036.48
Tangible assets total197.72196.32197.56200.11253.92
Investments total
Non-current loans receivable0.010.010.010.010.01
Long term receivables total0.010.010.010.010.01
Semifinished products7.9521.0729.6928.6529.63
Raw materials and consumables37.6251.3546.7442.8438.51
Finished products/goods42.7758.0942.8128.6539.17
Inventories total88.34130.50119.24100.14107.31
Current trade debtors100.5891.9484.3378.4597.31
Current amounts owed by group member comp.13.962.796.205.79
Prepayments and accrued income1.491.151.281.692.19
Current other receivables4.084.464.846.885.07
Current deferred tax assets0.70
Short term receivables total120.1198.2493.2493.22110.36
Other current investments17.66
Cash and bank deposits68.0349.6141.7532.8734.33
Cash and cash equivalents85.6949.6141.7532.8734.33
Balance sheet total (assets)492.95475.77453.35429.21508.92

Equity and liabilities (mDKK)

2021
2022
2023
2024
2025
Share capital0.200.200.200.200.20
Shares repurchased50.0045.00
Other reserves0.840.851.142.192.33
Retained earnings89.53101.65136.52108.39151.67
Profit of the financial year58.7735.3322.7132.5627.21
Minority interest (BS)10.7011.0110.0711.0411.17
Shareholders equity total210.05194.04170.64154.39192.58
Provisions17.4720.6521.9519.8724.84
Non-current loans from credit institutions53.7351.0748.4145.7262.15
Non-current liabilities total53.7351.0748.4145.7262.15
Current loans from credit institutions80.7390.85151.43146.28159.17
Current trade creditors27.2124.0526.3719.3435.05
Current owed to participating0.440.380.530.560.60
Current owed to group member44.19
Short-term deferred tax liabilities14.774.283.147.804.43
Other non-interest bearing current liabilities88.5446.2730.8835.2530.09
Current liabilities total211.70210.01212.35209.23229.35
Balance sheet total (liabilities)492.95475.77453.35429.21508.92
Page generated